MoneyWorks4Me

Everest Organics - Quaterly Results

27 May 2024 Evaluate
The total revenue for the quarter ended March 2024 remained nearly unchanged at Rs. 526.17 millions.Net Profit of the company move down -48.67% to Rs. 0.58  millions from Rs. 1.13 millions  in the same quarter last year.Operating profit for the quarter ended March 2024 rose to 32.57 millions as compared to 29.69 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 526.17 507.54 3.67 1972.41 1830.48 7.75 1972.41 1830.48 7.75
Other Income 2.97 6.89 -56.89 8.86 69.44 -87.24 8.86 69.44 -87.24
PBIDT 32.57 29.69 9.70 118.72 78.73 50.79 118.72 78.73 50.79
Interest 12.43 9.52 30.57 54.66 33.10 65.14 54.66 33.10 65.14
PBDT 20.14 20.17 -0.15 64.06 45.63 40.39 64.06 45.63 40.39
Depreciation 18.52 12.59 47.10 57.95 44.74 29.53 57.95 44.74 29.53
PBT 1.62 7.58 -78.63 6.11 0.89 586.52 6.11 0.89 586.52
TAX 1.04 6.45 -83.88 4.71 2.72 73.16 4.71 2.72 73.16
Deferred Tax 0.74 6.30 -88.25 3.71 2.57 44.36 3.71 2.57 44.36
PAT 0.58 1.13 -48.67 1.40 -1.83 -176.50 1.40 -1.83 -176.50
Equity 80.00 80.00 0.00 80.00 80.00 0.00 80.00 80.00 0.00
PBIDTM(%) 6.19 5.85 5.82 6.02 4.30 39.94 6.02 4.30 39.94
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..